K-numberK250684
Device nameOPUSWAVE Dual Sensor Imaging System
ApplicantTerumo Cardiovascular Systems Thi Plant
Product codeNQQ
Device classClass II
Decision dateJul 2, 2025
DecisionSubstantially Equivalent
Regulation892.1560
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The OPUSWAVE Dual Sensor Imaging System is a cart-based console that performs intravascular imaging of coronary arteries using both Optical Coherence Tomography (OCT) and Intravascular Ultrasound (IVUS) modalities simultaneously or sequentially through a single DualView Catheter. It is intended for patients undergoing transluminal interventional procedures and provides real-time grayscale imaging with measurement and analysis tools.

Technological characteristics

The device uses a Motor Drive Unit (MDU) connected to a DualView Catheter capable of dual imaging modalities at 40 MHz IVUS frequency and 1300 nm OCT wavelength with Class 1 laser output. It features a PC-based interface with keyboard and mouse, custom GUI, and supports image export via USB, DVD, network, and optical media. OCT imaging requires coronary flush (saline or contrast), while pullback can be automatic or manual.

Test standards cited

IEC 60601-1 for electrical safety, IEC 60601-1-2 for electromagnetic compatibility, IEC 60825-1 for laser safety classification, and FDA guidance for software in medical devices (Enhanced level documentation required).

Substantial equivalence argument

The device has identical intended use to predicate devices iLab Ultrasound Imaging System (K152316) and Ilumien Optis (K141453)—both intravascular coronary imaging for interventional procedures. Technological characteristics are equivalent: same form factor (cart-based console), same IVUS mode and frequency, similar OCT wavelength, equivalent user interfaces, and comparable safety/performance profiles. Design verification, validation, and animal testing demonstrated the device meets user needs without raising new safety or effectiveness issues. The dual-sensor capability is a combination of proven predicate technologies rather than a novel approach.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →